Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
BMC Genomics
|
October 10, 2021
Comparative transcriptomic analysis of races 1, 2, 5 and 6 of Fusarium oxysporum f.sp. pisi in a susceptible pea host identifies differential pathogenicity profiles
Saidi R Achari, Jacqueline Edwards, Ross C Mann, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1989
Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration
B A Boucher, A M Bombassaro, S N Rasmussen, et al.
Journal of Clinical Pharmacology
|
August 1, 1987
Esmolol-digoxin drug interaction
D T Lowenthal, R S Porter, R Achari, et al.
Journal of Clinical Pharmacology
|
January 1, 1987
Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist
R Achari, D Drissel, J D Hulse, et al.
Journal of Clinical Pharmacology
|
November 1, 1987
Pharmacokinetics of esmolol in hepatic disease
K N Buchi, D E Rollins, K G Tolman, et al.
BMC Genomics
|
March 22, 2020
Phylogenetic relationship between Australian Fusarium oxysporum isolates and resolving the species complex using the multispecies coalescent model
Saidi R Achari, Jatinder Kaur, Quang Dinh, et al.
Journal of Human Hypertension
|
April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacks
R R Luther, M J Klepper, C J Maurath, et al.
Indian Journal of Cancer
|
December 5, 2017
Continuous hyperfractionated accelerated radiotherapy using modern radiotherapy techniques for nonsmall cell lung cancer patients unsuitable for chemoradiation
R K Shrimali, M Arunsingh, A Das, et al.
Journal of Human Hypertension
|
April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacks
R R Luther, M J Klepper, C J Maurath, et al.
Journal of Clinical Pharmacology
|
March 10, 2000
Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers
W J Pan, L E Gustavson, R Achari, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
BMC Genomics
|
October 10, 2021
Comparative transcriptomic analysis of races 1, 2, 5 and 6 of Fusarium oxysporum f.sp. pisi in a susceptible pea host identifies differential pathogenicity profiles
Saidi R Achari, Jacqueline Edwards, Ross C Mann, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1989
Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration
B A Boucher, A M Bombassaro, S N Rasmussen, et al.
Journal of Clinical Pharmacology
|
August 1, 1987
Esmolol-digoxin drug interaction
D T Lowenthal, R S Porter, R Achari, et al.
Journal of Clinical Pharmacology
|
January 1, 1987
Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist
R Achari, D Drissel, J D Hulse, et al.
Journal of Clinical Pharmacology
|
November 1, 1987
Pharmacokinetics of esmolol in hepatic disease
K N Buchi, D E Rollins, K G Tolman, et al.
BMC Genomics
|
March 22, 2020
Phylogenetic relationship between Australian Fusarium oxysporum isolates and resolving the species complex using the multispecies coalescent model
Saidi R Achari, Jatinder Kaur, Quang Dinh, et al.
Journal of Human Hypertension
|
April 1, 1990
Effects of terazosin on serum lipid levels in hypertensive blacks
R R Luther, M J Klepper, C J Maurath, et al.
Indian Journal of Cancer
|
December 5, 2017
Continuous hyperfractionated accelerated radiotherapy using modern radiotherapy techniques for nonsmall cell lung cancer patients unsuitable for chemoradiation
R K Shrimali, M Arunsingh, A Das, et al.
Journal of Human Hypertension
|
April 1, 1990
Efficacy of terazosin in the treatment of essential hypertension in blacks
R R Luther, M J Klepper, C J Maurath, et al.
Journal of Clinical Pharmacology
|
March 10, 2000
Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers
W J Pan, L E Gustavson, R Achari, et al.
Page
of 6